Immunomodulating properties of protein hydrolysates for application in cow's milk allergy

Pediatric Allergy and Immunology

Volumn 26, Issue 3, 2015, Pages 206-217

  Kiewiet, M B G ^a   Gros, M ^b   van Neerven, R J J ^b   Faas, M M ^a   de Vos, P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

Author keywords

Epithelial barrier; Food allergy; Hydrolysates; Th1 Th2 balance; Toll like receptor

Indexed keywords

FOOD ANTIGEN; MILK PROTEIN; PROTEIN HYDROLYSATE; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; CELL MEMBRANE PERMEABILITY; FOOD ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MILK ALLERGY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN INTAKE; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BOVINE; DIET THERAPY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM;

ANIMALS; CATTLE; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; INTESTINAL MUCOSA; MACROPHAGES; MILK HYPERSENSITIVITY; PROTEIN HYDROLYSATES; RECEPTORS, PATTERN RECOGNITION; T-LYMPHOCYTES;

EID: 84928195887     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12354     Document Type: Review

References (71)

1. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010: 2: 131-43.
2. Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 2014: 8: 1008-25.
3. Sackesen C, Assa'ad A, Baena-Cagnani C, et al. Cow's milk allergy as a global challenge. Curr Opin Allergy Clin Immunol 2011: 11: 243-8.
4. Kneepkens CMF, Meijer Y. Clinical practice. diagnosis and treatment of cow's milk allergy. Eur J Pediatr 2009: 168: 891-6.
5. Estrada-Reyes E, Garcia-Hernandez G, Martinez-Gimeno A, Nava-Ocampo A. Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers. J Investig Allergol Clin Immunol 2006: 16: 183-7.
6. Terracciano L, Isoardi P, Arrigoni S, Zoja A, Martelli A. Use of hydrolysates in the treatment of cow's milk allergy. Ann Allergy Asthma Immunol 2002: 89: 86-90.
7. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008: 8: 411-20.
8. Henderson TR, Hamosh M, Armand M, Mehta NR, Hamosh P. Gastric proteolysis in preterm infants fed mother's milk or formula. Adv Exp Med Biol 2001: 501: 403-8.
9. Washington N, Spensley P, Smith C, et al. Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis. Arch Dis Child 1999: 81: 309-12.
10. Yu LC. Intestinal epithelial barrier dysfunction in food hypersensitivity. J Allergy 2012: 2012: 596081.
11. Weaver L, Laker RM, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984: 59: 236-41.
12. Mayer L. Mucosal immunity. Pediatrics 2003: 111: 1595-600.
13. van Elburg R, Fetter W, Bunkers C, Heymans H. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child 2003: 88: 52-5.
14. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011: 141: 769-76.
15. Johansson MEV, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013: 10: 352-61.
16. Jayashree B, Bibin YS, Prabhu D, et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2013: 388: 203-10.
17. Thakar M, Vogel S, Kao J, Fasano A. The vibrio cholerae-generated zonula occludens toxin (zot) N-terminal cleavage site contains a protease-activated receptor activating peptide (PAR-AP) that retains biological activity on intestinal tight junctions. Gastroenterology 2005: 128: A541.
18. Macdonald T. The mucosal immune system. Parasite Immunol 2003: 25: 235-46.
19. Owen R, Pierce N, Apple R, Cray W. M-cell transport of vibrio-cholerae from the intestinal lumen into peyers-patches - a mechanism for antigen sampling and for microial trans-epithelial migration. J Infect Dis 1986: 153: 1108-18.
20. Schulz O, Jaensson E, Persson EK, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009: 206: 3101-14.
21. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011: 241: 241-59.
22. Manicassamy S, Reizis B, Ravindran R, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010: 329: 849-53.
23. Komai-Koma M, Jones L, Ogg G, Xu D, Liew F. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004: 101: 3029-34.
24. Strobel S. Understanding primary oral tolerance induction: the end of the beginning. Monatsschr Kinderheilkd 2003: 151: S10-6.
25. Kim H, Hwang S, Kim B, Jung K, Chung D. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 2006: 118: 101-11.
26. Takatsu K. Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med 1997: 215: 121-33.
27. van Wijk F, Knippels L. Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization. Biomed Pharmacother 2007: 61: 8-20.
28. Steele L, Mayer L, Berin MC. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res 2012: 54: 75-82.
29. Barbara G. Mucosal barrier defects in irritable bowel syndrome. who left the door open? Am J Gastroenterol 2006: 101: 1295-8.
30. He S, Liu Z, Chen X, et al. IL-9+IL-10+T cells link immediate allergic response to late phase reaction. Clin Exp Immunol 2011: 165: 29-37.
31. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of treg in immune regulation of allergic diseases. Eur J Immunol 2010: 40: 1232-40.
32. Macfarlane A, Kon O, Smith S, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000: 105: 99-107.
33. Langrish C, Chen Y, Blumenschein W, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005: 201: 233-40.
34. Huber S, Gagliani N, Flavell RA. Life, death, and miracles: th17 cells in the intestine. Eur J Immunol 2012: 42: 2238-45.
35. Esplugues E, Huber S, Gagliani N, et al. Control of T(H)17 cells occurs in the small intestine. Nature 2011: 475: 514-U114.
36. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008: 14: 282-9.
37. Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells. J Allergy Clin Immunol 2009: 123: 1244-52.
38. Herberth G, Daegelmann C, Roder S, et al. IL-17E but not IL-17A is associated with allergic sensitization: results from the LISA study. Pediatr Allergy Immunol 2010: 21: 1086-90.
39. Bin DK, d'Hennezel E, Ben-Shoshan M, et al. Altered T helper 17 responses in children with food allergy. Int Arch Allergy Immunol 2013: 162: 318-22.
40. Tanabe S. Analysis of food allergen structures and development of foods for allergic patients. Biosci Biotechnol Biochem 2008: 72: 649-59.
41. Brand PLP, Rijk-van Gent H. [Cow's milk allergy in infants: new insights]. Ned Tijdschr Geneeskd 2011: 155: A3508.
42. Wichers H. Immunomodulation by food: promising concept for mitigating allergic disease? Anal Bioanal Chem 2009: 395: 37-45.
43. Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003: 9: 1297-308.
44. Jaziri M, Miglioresamour D, Casabiancapignede M, Keddad K, Morgat J, Jolles P. Specific binding-sites on human phagocytic blood-cells for gly-leu-phe and val-glu-pro-ile-pro-tyr, immunostimulating peptides from human-milk proteins. Biochim Biophys Acta 1992: 1160: 251-61.
45. Iskandar MM, Dauletbaev N, Kubow S, Mawji N, Lands LC. Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to toll-like receptor 4. Br J Nutr 2013: 110: 58-68.
46. Ndiaye F, Tri V, Duarte J, Aluko RE, Matar C. Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds. Eur J Nutr 2012: 51: 29-37.
47. Visser JTJ, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012: 28: 505-13.
48. Visser JT, Lammers K, Hoogendijk A, et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010: 53: 2621-8.
49. Nielsen DSG, Theil PK, Larsen LB, Purup S. Effect of milk hydrolysates on inflammation markers and drug-induced transcriptional alterations in cell-based models. J Anim Sci 2012: 90: 403-5.
50. Swiatecka D, Markiewicz LH, Wroblewska B. Pea protein hydrolysate as a factor modulating the adhesion of bacteria to enterocytes, epithelial proliferation and cytokine secretion - an in vitro study. Cent Eur J Immunol 2012: 37: 227-31.
51. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003: 18: 479-97.
52. Oseguera-Toledo ME, Gonzalez dME, Dia VP, Amaya-Llano SL. Common bean (Phaseolus vulgaris L.) hydrolysates inhibit inflammation in LPS-induced macrophages through suppression of NF-kappa B pathways. Food Chem 2011: 127: 1175-85.
53. Kleinert H, Pautz A, Linker K, Schwarz P. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004: 500: 255-66.
54. de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappa B pathway in the macrophage. Peptides 2009: 30: 2388-98.
55. Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappa B. Proc Natl Acad Sci USA 2009: 106: 14978-83.
56. Kang YH, Biswas SK. Basophil-macrophage dialog in allergic inflammation. Immunity 2013: 38: 408-10.
57. Tavares TG, Spindola H, Longato G, Pintado ME, Carvalho JE, Malcata FX. Antinociceptive and anti-inflammatory effects of novel dietary protein hydrolysate produced from whey by proteases of cynara cardunculus. Int Dairy J 2013: 32: 156-62.
58. Wong K, Middleton N, Montgomery M, Dey M, Carr R. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J Dairy Sci 1998: 81: 1825-32.
59. Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 2006: 16: 1315-23.
60. Tang C, Inman M, van Rooijen N, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001: 166: 1471-81.
61. Knipping K, van Esch BCAM, van Ieperen-van Dijk AG, et al. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation. Int Arch Allergy Immunol 2012: 159: 263-70.
62. Mao XY, Yang HY, Song JP, Li YH, Ren FZ. Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro. J Agric Food Chem 2007: 55: 638-42.
63. Wu G, Tsai G. Immunomodulatory effects of oral administration of chitosan hydrolysate in BALB/c mice. Taiwanese J Agricult Chem Food Sci 2006: 44: 228-34.
64. Cian RE, Lopez-Posadas R, Drago SR, Sanchez dMF, Martinez-Augustin O. A porphyra columbina hydrolysate upregulates IL-10 production in rat macrophages and lymphocytes through an NF-kappa B, and p38 and JNK dependent mechanism. Food Chem 2012: 134: 1982-90.
65. Lahart N, O'Callaghan Y, Aherne SA, O'Sullivan D, FitzGerald RJ, O'Brien NM. Extent of hydrolysis effects on casein hydrolysate bioactivity: evaluation using the human jurkat T cell line. Int Dairy J 2011: 21: 777-82.
66. Duan C, Huo G, Yang L, Ren D, Chen J. Comparison of sensitization between beta-lactoglobulin and its hydrolysates. Asian Pac J Allergy Immunol 2012: 30: 32-9.
67. Gangloff S, Guenounou M. Toll-like receptors and immune response in allergic disease. Clin Rev Allergy Immunol 2004: 26: 115-25.
68. Duechs MJ, Hahn C, Benediktus E, et al. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm Pharmacol Ther 2011: 24: 203-14.
69. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001: 357: 1076-9.
70. Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008: 47: 171-82.
71. Pan DD, Wu Z, Liu J, Cao XY, Zeng XQ. Immunomodulatory and hypoallergenic properties of milk protein hydrolysates in ICR mice. J Dairy Sci 2013: 96: 4958-64.